Halaven
Payments companies reported to CMS as associated with Halaven. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Halaven, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Halaven
These are the largest totals companies reported as associated with Halaven. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Peter Kaufman | Lebanon, NH | Medical Oncology | $20,138.75 |
| Joyce O'Shaughnessy | Dallas, TX | Medical Oncology | $5,780.00 |
| Sarah Schellhorn | New Haven, CT | Medical Oncology | $4,080.00 |
| Sara Tolaney | Boston, MA | Hematology & Oncology | $3,400.00 |
| Nancy Lin | Boston, MA | Hematology & Oncology | $1,900.00 |
| Komal Jhaveri | New York, NY | Medical Oncology | $1,700.00 |
| Timothy Pluard | Kansas City, MO | Medical Oncology | $68.00 |
Prescribed Halaven?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.